Evidence map›Paper›PMID 26777473›Full record

ArticleJournal of neuroscience methods2016

Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters.

Lyle Wiemerslage, Daewoo Lee

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Lyle WiemerslageFunctional Pharmacology, Department of Neuroscience, Biomedicinska Centrum, Uppsala University, Husargatan 3, Box 593, 75124 Uppsala, Sweden. Electronic address: lyle.wiemerslage@neuro.uu.se.
Daewoo LeeNeuroscience Program, Department of Biological Sciences, Ohio University, Athens, OH 45701, United States. Electronic address: leed1@ohio.edu.
Ohio University · USUppsala University · SE

Funding

Role of dopamine in alpha-Syn-mediated neurodegenerationR21NS050260 · NINDS · OHIO UNIVERSITY ATHENS · PI LEE, DAEWOO · 2005 to 2006
$336k
NINDS NIH HHS NS050260NINDS NIH HHS R21 NS050260
6 · The paper itself

Abstract

backgroundStudies of mitochondrial morphology vary in techniques. Most use one morphological parameter while others describe mitochondria qualitatively. Because mitochondria are so dynamic, a single parameter does not capture the true state of the network and may lead to erroneous conclusions. Thus, a gestalt method of analysis is warranted. NEW

methodThis work describes a method combining immunofluorescence assays with computerized image analysis to measure the mitochondrial morphology within neuritic projections of a specific population of neurons. Six parameters of mitochondrial morphology were examined utilizing ImageJ to analyze colocalized signals.

resultsUsing primary neuronal cultures from Drosophila, we tested mitochondrial morphology in neurites of dopaminergic (DA) neurons. We validate our model using mutants with known defects in mitochondrial morphology. Furthermore, we show a difference in mitochondrial morphology between cells treated as control or with a neurotoxin inducing PD (Parkinson's Disease in humans)-like pathology. We also show interactions between morphological parameters and experimental treatment. COMPARISON WITH EXISTING

methodsOur method is a significant improvement of previously described methods. Six morphometric parameters are quantified, providing a gestalt analysis of mitochondrial morphology. Also it can target specific populations of mitochondria using immunofluorescence assay and image analysis.

conclusionsWe found that our method adequately detects differences in mitochondrial morphology between treatment groups. We conclude that some parameters may be unique to a mutation or a disease state, and the relationship between parameters is altered by experimental treatment. We suggest at least four variables should be considered when using mitochondrial structure as an experimental endpoint.

Indexed as

AnimalsAnimals, Genetically ModifiedAnimals, NewbornCells, CulturedCytoskeletal ProteinsDopaminergic NeuronsDrosophilaDrosophila ProteinsEmbryo, NonmammalianGreen Fluorescent ProteinsGTP-Binding ProteinsImage Processing, Computer-AssistedMembrane ProteinsMicroscopy, ElectronMitochondriaNeuritesCytoskeletal ProteinsDrosophila ProteinsDRP1 protein, DrosophilaGreen Fluorescent ProteinsGTP-Binding ProteinsMembrane ProteinsOPA1 protein, DrosophilaDrosophiladrp1Mitochondriaopa1Parkinson

Identifiers

PMID26777473
PMCPMC4775301
OpenAlexW2260239598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.